首页> 外文期刊>Annals of Nuclear Medicine and Molecular Imaging >Recurrent Metastatic Papillary Thyroid Carcinoma in a Patient with Graves' Disease that Manifested after Lobectomy for Thyroid Cancer: Case Report
【24h】

Recurrent Metastatic Papillary Thyroid Carcinoma in a Patient with Graves' Disease that Manifested after Lobectomy for Thyroid Cancer: Case Report

机译:甲状腺癌术后患者患者患者复发转移性乳头状甲状腺癌:案例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Concomitant Graves' disease (GD) with differentiated thyroid cancer (DTC) is not uncommon, but evident hyperthyroidism after thyroid tumor resection is unusual and has been termed "post-thyroidectomy Graves' disease (PTGD)." The damage to thyroid epithelium resulting from surgery may be associated with TSH receptor antibody (TRAb) production, which is thought to be the main etiology of PTGD. If PTGD occurs in DTC patients without tumor cell eradication, it is very likely that the residual tumors, with constant stimulation from circulating TRAb, will continue proliferating and become extensive disease. In this report, we describe an interesting case of hyperthyroid GD noted three years, and pulmonary metastases presenting 10 years after hemi-thyroidectomy for DTC. Loco-regional tumors were detected due to I-131 treatment of recurrent hyperthyroidism while the pulmonary metastases were uncovered after high-activity I-131 treatment of the loco-regional disease. We speculate that the hyperthyroid GD might be associated with prior thyroid surgery and the tumor metastasis was probably facilitated by elevated serum TRAb secondary to the GD. Herein we particularly emphasize the assessment of any residual or recurrent tumor before I-131 treatment is to be used for GD after thyroidectomy for DTC.
机译:伴随的甲状腺癌(DTC)伴随着坟墓(GD)并不罕见,但在甲状腺肿瘤切除后明显的甲状腺功能亢进是不寻常的,并且已被称为“甲状腺切除术后坟墓”(PTGD)。“由手术产生的甲状腺上皮损伤可能与TSH受体抗体(TRAB)生产相关,这被认为是PTGD的主要病因。如果PTGD发生在没有肿瘤细胞的DTC患者中,则很可能是循环循环循环循环的残留肿瘤,将继续增殖并变得广泛疾病。在本报告中,我们描述了甲状腺功能亢进GD的有趣情况,并注意到患有DTC的半甲状腺切除术后10年的肺转移。由于I-131治疗反复性甲状腺功能亢进的I-131治疗而检测到基因群肿瘤,同时在高活性I-131治疗基因群区域疾病后发现肺转移。我们推测甲状腺功能亢进GD可能与先前的甲状腺手术相关,并且血清TRAB次级血清TRAB升高的血清TRAB可能促进肿瘤转移。在此,我们特别强调在甲状腺切除术中用于DTC后的GD之前对任何残留或复发性肿瘤的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号